Lupin Turns Up Heat With Bausch Brands Acquisition, Perforomist Generic Launch

Spiriva Launch Awaited, Seeks Xopenex Gains

Two acquisitions of brands in as many months, Lupin has stepped up its game in the Americas. A buyout of nine established Bausch Health brands follows rights to two from Sunovion. While it awaits news on generic(g) Spiriva, the launch of gPerforomist will help expand Lupin’s respiratory franchise

Acquisition of assets
Lupin Is Adding To Its Portfolio In The Americas Via Acquisitions • Source: Shutterstock

Lupin Limited is stepping up its game in the Americas, with its second acquisition of brands in as many months. The recent acquisition in Brazil from Bausch Health Companies Inc. gives it access to a basket of nine diverse yet established brands for an undisclosed amount.

Lupin has a presence in Brazil via a wholly owned subsidiary MedQuímica Indústria Farmacêutica (MedQuímica), which signed the agreement to...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip